VKTX

$27.97+7.21%visit website

Viking Therapeutics, Inc.

Market Cap

$3.6B

Live price × SEC shares (Oct 15, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.73

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

6.1

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	0.00	0.00	0.00	0.00	0.00
Research & development	153,459	150,150	115,754	166,804	586,167
Total operating expenses	164,738	164,125	132,597	187,112	648,572
Operating income	(164,738)	(164,125)	(132,597)	(187,112)	(648,572)
Interest expense				88.0
Net income	(157,662)	(158,325)	(128,022)	(183,186)	(627,195)
EPS (basic) ($)		(1.37)	(1.10)	(1.55)	(5.42)
EPS (diluted) ($)		(1.37)	(1.10)	(1.55)	(5.42)
Weighted avg. shares (basic)		115,568	116,263	118,050
Weighted avg. shares (diluted)		115,568	116,263	118,050

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 29, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 47 more quarters, back to Mar 2014, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 28, 2026 accepted 4:10 PM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

31%

W/W -13.3pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-29	2026-07-29	Lian Brian	Director & President & CEO	Sale	148.5K	$33.32	$4.95M	2.57M	View
2026-07-29	2026-07-29	Mancini Marianna	Chief Operating Officer	Sale	18.2K	$33.47	$610K	422.8K	View
2026-07-29	2026-07-29	ZANTE GREG	Chief Financial Officer	Sale	21.2K	$33.47	$710K	212.2K	View
2026-03-10	2026-03-10	Aubuchon Neil William	Chief Commercial Officer	Purchase	4,475	$33.50	$150K	4,475	View

Recent News

Viking Therapeutics Trades 23% Below Its Own $35 Secondary Offering Price. Here's Why That Could Be a Gift for Patient Investors.

Yahoo Finance · 2026-11-04

Viking Therapeutics to Participate at Upcoming Investor Conferences

Yahoo · 2026-11-03

Novo Before Q3 Earnings: How Should Investors Play the Stock?

Yahoo · 2026-11-02

UBS Just Initiated Coverage of Viking Therapeutics With a Buy Rating and a $94 Target. Here's the Bull Case.

Yahoo · 2026-11-02

Viking Therapeutics: A Strong Injection, A Scaled-Back Pill

SeekingAlpha · 2026-10-31

Canaccord Genuity Maintains Buy on Viking Therapeutics, Raises Price Target to $118

Benzinga · 2026-10-30

VKTX: Is a 2029 Launch for Its Obesity Drug Within Reach?

Yahoo · 2026-10-30

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

Yahoo · 2026-10-30

Viking Therapeutics: Q3 Update - Why You Can't Discount This GLP-1 Player (Yet)

SeekingAlpha · 2026-10-29

VKTX Q3 Earnings Miss Estimates Amid Rising Clinical Expenses

Yahoo · 2026-10-29

Viking Therapeutics Stock Jumps: What's Going On? - Viking Therapeutics (NASDAQ:VKTX)

Benzinga · 2026-10-29

LLY Stock Jumps as Q3 Earnings Beat Estimates, 2026 Sales View Raised

Yahoo · 2026-10-29

Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases

Yahoo · 2026-10-29

VKTX Q3 Earnings Call Highlights Obesity Pipeline Progress

Yahoo · 2026-10-29

Viking Therapeutics, Inc. Q3 2026 Earnings Call Summary

Yahoo Finance · 2026-10-29

Informational purposes only, not investment advice.

VKTX

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Viking Therapeutics, Inc. (VKTX)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-07-29	Lian Brian	S	148,517	$5M
2026-07-29	Mancini Marianna	S	18,217	$609,635.55
2026-07-29	ZANTE GREG	S	21,217	$710,141.48
2026-03-10	Aubuchon Neil William	P	4,475	$149,912.5